Novartis to present first IL-17A Phase III data for AIN457 (secukinumab) in psoriatic arthritis and ankylosing spondylitis at ACR 2014

Nov 10, 2014

AddToAny buttons

Share Tweet Share Whatsapp Linkedin Email

Printable Links Block (Content)